Global Non-Viral Transfection Reagents and Systems Market
Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents and Systems Market (2nd Edition) by Type of Non-Viral Transfection...
Source: globenewswire.com
Page 2 - Technology Competitiveness Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Technology Competitiveness Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Technology Competitiveness Analysis Today - Breaking & Trending Today
Insights on the Non-Viral Transfection Reagents and Systems Global Market to 2035: by Type of Non-Viral Transfection Method, End-User, Application Areas and Key Geographical Regions
/PRNewswire/ -- The "Non-Viral Transfection Reagents and Systems Market (2nd Edition) by Type of Non-Viral Transfection Method, End-User, Application Areas and...
Source: prnewswire.com
Insights on the RNAi Therapeutics and Technologies Global Market to 2035
/PRNewswire/ -- The "RNAi Market: Therapeutics and Technologies by Key Therapeutic Areas, Route of Administration, Leading Industry Players, Type of RNAi...
Source: prnewswire.com
Global Non-Viral Drug Delivery Systems Market Trends and Forecasts Report 2021: Extensive Study of the Current Landscape and the Likely Opportunities in Intracellular Drug Delivery Technologies
Share this article Share this article ResearchAndMarkets.com's offering. The "Non-Viral Drug Delivery Systems: Focus on Intracellular Technologies and Intracellular Biologics Market, 2021-2030" report features an extensive study of the current landscape and the likely future opportunities in intracellular drug delivery technologies market for the next 10 years. One of the key objectives of the report was to estimate the existing market size and identify potential future growth opportunities for intracellular drug delivery technologies. Based on likely licensing deal structures and agreements ...
Source: prnewswire.com